CookS.D., DowlingP.C.. The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome.Ann Neurol1981; 9(Suppl): 70–9
3.
SaidaT., SaidaK., LisakR.P., BrownM.J., SilberbergD.H., AsburyA.K.. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome.Ann Neurol1982; 11: 69–75
4.
FeasbyT.E., HahnA.F., GilbertJ.J.. Passive transfer studies in Guillain-Barré polyneuropathy.Neurology (NY)1982; 32: 1159–67
5.
KoskiC.L., HumphreyR., ShinM.L.. Anti-peripheral myelin antibodies in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibodies by complement component and fixation.Proc Natl Acad Sci USA1985; 82: 905–9
6.
BrettleR.P., GrossM., LeggN.J., LockwoodM., PallisC.. Treatment of acute polyneuropathy by plasma exchange.Lancet1978; ii: 1100
7.
CookJ.D., TindallR.A.S., WalkerJ., KhanA., RosenbergR.. Plasma exchange as a treatment of acute and chronic idiopathic autoimmune polyneuropathy: limited success.Neurology (Minneap)1980; 30: 361
8.
RailD., StarkR., SwashM., NewlandA.. Improvement in nerve conduction after plasma exchange for Guillain-Barré syndrome.J Neurol Neurosurg Psychiatry1980; 43: 1147
9.
ValbonesiM., GarelliS., MosconiL., ZerbiD., CelanoI.. Plasma exchange as therapy for Guillain-Barré syndrome with immune complexes.Vox Sang1981; 41: 74–8
10.
DurwardW.F., BurnettA.K., WatkinsR., ReidJ.M.. Plasma exchange in Guillain-Barré syndrome.Br Med J1981; 283: 794
11.
OstermanP.O., FagiusJ., SafwenbergJ., DanersundA., Gunnar WallingB., NordesjoL.O.. Treatment of Guillain-Barré syndrome by plasmapheresis.Arch Neurol1982; 39: 148–54
12.
GrossM.L.P., LeggN.J., LockwoodM.C., PallisC.. The treatment of inflammatory polyneuropathy by plasma exchange.J Neurol Neurosurg Psychiatry1982; 45: 675–9
13.
KennardC., NewlandA.C., RidleyA.. Treatment of the Guillain-Barré syndrome by plasma exchange.J Neurol Neurosurg Psychiatry1982; 42: 847–50
GreenwoodR.J., Newsom DavisJ., HughesR.A.C., AslanS., BowdenA.N., ChadwickD.W.Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy.Lancet1984; i: 877–9
16.
OstermanP.O., LundemoG., PirskanenR., FagiusJ., PihlstedtP., SidenA., SafwenbergJ.. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.Lancet1984; 2: 1296–9
17.
MendellJ.R., KisselJ.T., KennedyM.S.Plasma exchange in acute inflammatory polyradiculoneuropathy. A controlled randomised trial.Ann Neurol1983; 14: 122
18.
RaphaelJ.C., ChastangC.. Cooperative randomised trial of plasma exchange in Guillain-Barré syndrome. Preliminary results.Ann Med Interne (Paris)1984; 135: 8
19.
Guillain-Barré Syndrome Study Group.Plasmapheresis and acute Guillain-Barré syndrome.Neurology1985; 35: 1096–104
20.
Consensus Conference. The utility of therapeutic plasmapheresis for neurological disorders.Statement.JAMA1986; 256: 1333–7
21.
AsburyA.K., ArnasonB.G.W., KarpH.R., McFarlinD.E.. Criteria for diagnosis of Guillain-Barré syndrome.Ann Neurol1978; 2: 565–6
22.
WinerJ., HughesR.A.C.. A prospective study of Guillain-Barré syndrome (1) Clinical features and their prognostic value.J Neurol Neurosurg Psychiatry1988; 51: 605–12
23.
WinerJ., HughesR.A.C., GreenwoodR., HealyM.H.. Prognosis in the Guillain-Barré syndrome.Lancet1985; i: 1202–3
24.
HuestisD.W.. Mortality in therapeutic haemapheresis.Lancet1983; i: 1043
25.
GajdosP.H., PourratJ., ElkharratD., TerreC.. National Register for plasma exchange - The French Society for Hemapheresis. Results for 1985.Plasma Ther Transfus Technol1987; 8: 137–41